US Stocks
/
Summit Therapeutics Inc. Share Price
Summit Therapeutics Inc. Share Price

Summit Therapeutics Inc. Share Price

NASDAQ: SMMT | Large Cap
$17.36
+$0.18 (1.02%) Last updated on 09 Oct, 2026 | 22:16 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Summit Therapeutics Inc. Stock Performance

Open
$17.34
Prev. Close
$17.18
Circuit Range
N/A
Day Range
$16.82 - $17.50
Year Range
$12.07 - $29.21
Volume
2,54,552
Average Traded
$17.23

Summit Therapeutics Inc. Share Price Today

As of 9 October 2026, Summit Therapeutics Inc.'s share price is $17.36. The stock opened at $17.34, compared to its previous close of $17.18. During today's trading session, Summit Therapeutics Inc.'s share price traded between $16.82 and $17.50, with an average price of $17.16. Over the past 52 weeks, the stock has recorded a high of $29.21 and a low of $12.07. In terms of performance, Summit Therapeutics Inc.'s share price has declined by 19.12% over the last six months and is down 8.15% on a year-on-year basis.

Summit Therapeutics Inc. Share Price Chart

$16.82$17.50
L
Show Current Price
H

Summit Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
$12.98B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.07
Revenue (TTM)
$0.00
Return On Equity (TTM)
-135.90%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
6.93%

Summit Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$231.79-$219.17-$189.42-$215.73
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A5.44%13.57%-13.89%

Summit Therapeutics Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.71$0.00$0.00$0.00
Net Profit-$78.78-$614.93-$221.32-$1079.59
Net Profit Margin-11095.77%N/AN/AN/A
Income ChangeN/A-680.57%64.01%-387.80%

About Summit Therapeutics Inc.

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.

Summit Therapeutics Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$16.85
$17.34
+2.39%
Sep 2026
$13.47
$16.93
+18.10%
Aug 2026
$13.07
$14.34
+10.14%
Jul 2026
$14.54
$13.02
-10.64%
Jun 2026
$16.72
$14.57
-16.89%
May 2026
$16.02
$17.53
-18.33%
Apr 2026
$19.17
$21.46
+13.27%
Mar 2026
$16.16
$18.95
+14.16%
Feb 2026
$14.24
$16.60
+14.72%
Jan 2026
$17.66
$14.47
-17.29%
Dec 2025
$17.36
$17.50
-2.15%
Nov 2025
$18.86
$17.88
-5.40%

SMMT Share Price FAQs

What is Summit Therapeutics Inc. share price today?

chevron-up
Summit Therapeutics Inc. share price today is $17.36 as on October 9, 2026 at 10:16 pm IST.

What is the 52 week high and 52 week low of Summit Therapeutics Inc. stock?

chevron-up
The 52 week high of Summit Therapeutics Inc. stock is $29.21, while the 52 week low is $12.07 as of 9 Oct '26.

What is SMMT's market capitalisation today?

chevron-up
SMMT market capitalisation is $12.98B as of October 9, 2026, at 10:17 pm IST.

What is SMMT's net income for the last quarter?

chevron-up
SMMT's net income for the last quarter is -215.73B USD.

What is the 5 year returns of SMMT?

chevron-up
The 5 year returns of SMMT is 236.43% as on 9 Oct '26.

What is the high & low stock price of SMMT today?

chevron-up
SMMT stock price hit a high of $17.50 and low of $16.82 as of 9 Oct '26.

Can I buy SMMT shares in India?

chevron-up
Yes. You can buy SMMT in India by opening an international trading account.